Healthcare - Biotechnology - NASDAQ - US
$ 0.68
8.59 %
$ 3.94 M
Market Cap
-0.11
P/E
CASH FLOW STATEMENT
-40.9 M
OPERATING CASH FLOW
-14.3 K
INVESTING CASH FLOW
4.49 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Hepion Pharmaceuticals, Inc.
| Net Income | -48.9 M |
| Depreciation & Amortization | 67.1 K |
| Capital Expenditures | -14.3 K |
| Stock-Based Compensation | 1.34 M |
| Change in Working Capital | 2.97 M |
| Others | 6.74 M |
| Free Cash Flow | -40.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (48.9) | (42.2) | (32.7) | (20.4) | (7.0) | (9.4) | (15.0) | (14.9) | (17.0) | (14.3) | (5.3) | 843 |
| Depreciation & Amortization | 67.1 K | 77.5 K | 86.1 K | 34.5 K | 26.7 K | 18.8 K | 21.9 K | 28 K | 21.5 K | 16.4 K | 1.32 K | 0 |
| Deferred Income Tax | (0.4) | 1.9 | 0 | 6.05 K | 48.3 K | (0.5) | (0.4) | (4.2) | 0 | 0.4 | 0 | 0 |
| Stock Based Compensation | 1.3 | 2.6 | 4.7 | 2.4 | 66.2 K | 0.2 | 1.57 K | 1.7 | 0.9 | 2.1 | 0.2 | 0 |
| Other Operating Activities | 4.1 | (0.4) | 2.3 | 0.1 | 0.2 | (4.9) | 7.3 | (4.2) | (3.8) | 1.6 | 3.6 | 763 |
| Change in Working Capital | 3.0 | 3.2 | (5.6) | 1.6 | (0.8) | (1.0) | 19.2 K | (1.8) | 3.3 | 1.0 | 0.1 | 0 |
| Cash From Operations | (40.9) | (35.0) | (31.2) | (16.2) | (7.6) | (15.6) | (8.2) | (19.2) | (16.6) | (9.7) | (1.4) | 79.7 |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 14.3 K | 16.3 K | (0.1) | 88 K | 51.5 K | 0 | 2.42 | 14.7 K | 6.6 K | 83.3 K | 15.8 K | 0 |
| Other Items | 0 | 2.27 K | 0 | 2.19 K | 0 | 900 | 0 | 0 | (0.5) | 0 | 0 | 0 |
| Cash From Investing Activities | 14.3 K | 14.1 K | (0.1) | 85.8 K | 51.5 K | 900 | 2.42 | 14.7 K | (0.5) | 83.3 K | 15.8 K | 0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | (21.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.2) | 0.2 | (1.1) | 1.3 | 0 | 10.4 K | 0 | 0 | 100 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 4.5 | (5.1) | 0 | 12 K | 12.1 | 9.6 | 11.9 | 0.1 | 19.9 | 12.5 | 15 K | 600 |
| Cash From Financing Activities | 4.5 | (5.1) | 82.0 | 43.1 | 18.7 | 12.5 | 1.2 | 24.8 | 19.9 | 12.5 | 3.1 | 600 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (36.4) | (40.2) | 50.6 | 26.8 | 11.1 | (3.1) | (1.4) | 5.6 | 2.8 | 2.7 | 1.7 | 520 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (40.9) | (35.0) | (31.4) | (16.3) | (7.6) | (15.6) | (8.2) | (19.2) | (16.6) | (9.8) | (1.4) | 79.7 |